This site contains promotional information intended only for healthcare professionals resident in the United Kingdom

Visit Pfizer Medical site

Menu

Close

Sign InLog Out
  • EN
Single LinkDropdownLabelLinkLinkLinkLinkLinked DropdownLabelLinkLinkLinkLinkMega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLink
Linked Mega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLink
EN - EnglishSelect a languageLanguagesEN - EnglishFR - Françias

Menu

Close

Sign InLog Out
  • EN
Single LinkDropdownLabelLinkLinkLinkLinkLinked DropdownLabelLinkLinkLinkLinkMega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLink
Linked Mega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLink
EN - EnglishSelect a languageLanguagesEN - EnglishFR - Françias
Search

Menu

Close

Sign In or RegisterLog Out
Pfizer MedicinesTherapy AreasExplore ContentEventsVideosMaterialsFeatured ArticlesLet’s ConnectSupplyAlliance HealthcareOff-contract claims

Adverse event reporting can be found at the bottom of the page

HomeHomeVaccines HomepageLoadingDisease AreasDisease AreasRespiratory Syncytial Virus (RSV)Pneumococcal diseaseTick-borne encephalitis (TBE)Meningococcal diseaseDisease Areas

Menu

Close

Our BrandsOur BrandsABRYSVO® (respiratory syncytial virus vaccine (bivalent, recombinant))Nimenrix® (meningococcal groups A, C, W-135 and Y conjugate vaccine)Trumenba® (meningococcal group B vaccine (recombinant, adsorbed))Prevenar 13® (pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed))TicoVac® (tick-borne encephalitis vaccine (whole virus inactivated))Vaccine TechnologiesVaccine TechnologiesMaternal ImmunisationConjugate TechnologyPolysaccharide VaccinesInactivated VaccinesSupport & ResourcesSupport & ResourcesClinic support materials

Prescribing Information can be found at the bottom of the page.

Inactivated Vaccines

Inactivated Vaccines are developed using a live pathogen that is inactivated or killed so that it can no longer replicate itself.1  This means that when the inactivated vaccine is given, the pathogen is strong enough to generate an immune response, but without causing disease.1  

This makes this form of vaccine much more suitable than live vaccines for those people suffering with immunocompromised conditions.1

Because inactivated vaccines do not contain live pathogens, they may not be as effective at stimulating a strong or long-lasting immune response. This means that multiple doses of the vaccine may be necessary to build up sufficient immunity, and periodic booster vaccines may be needed to maintain immunity over time.2,3

Pfizer's Inactivated Vaccines


Pfizer currently offers two Inactivated Vaccines.


TicoVac® (Tick-Borne Encephalitis Vaccine (whole Virus inactivated)) for immunisation against Tick-Borne Encephalitis (TBE) in persons aged 16 years of age and older.4

TicoVac® Junior (Tick-Borne Encephalitis Vaccine (whole Virus inactivated)) for immunisation against Tick-Borne Encephalitis (TBE) in children aged from 1 years to 15 years.5

Click on the button to right to visit the TicoVac brand site.

Discover TicoVac
Loading
Order Clinic Materials

Help your customers to feel confident about vaccination - access MedISA to order printed clinic support materials to your surgery, pharmacy or other healthcare centre.

Order materials nowLoading
Register to receive personalised marketing information from Pfizer by email

Stay up to date with the latest relevant healthcare, medical and promotional information about medicines and vaccines promoted by Pfizer.

Sign up hereLoading


Prescribing Information

TicoVac (Tick-Borne Encephalitis Vaccine (whole Virus inactivated)) 0.5 ml Suspension for injection in a prefilled syringe
TicoVac Junior (Tick-Borne Encephalitis Vaccine (whole Virus inactivated)) 0.25 ml Suspension for injection in a pre-filled syringe

References:

1. Oxford Vaccine Group. Vaccine Knowledge Project. Types of vaccine. Last accessed April 2023

2. Vaccines Europe. Types of vaccines. Last accessed April 2023.
3. GAVI. What are whole virus vaccines and how could they be used against COVID-19? Last access April 2023.
4. TicoVac (Tick-Borne Encephalitis Vaccine). Summary of Product Characteristics. https://medicines.org.uk/emc/product/1923/smpc. Last accessed April 2023.
5. TicoVac Junior (Tick-Borne Encephalitis Vaccine). Summary of Product Characteristics. https://medicines.org.uk/emc/product/1927/smpc. Last accessed April 2023.

​​
References:
  1. Public Health England. The Green Book [published 2013; updated 2020]. Chapter 25: Pneumococcal. Available at https://www.gov.uk/government/publications/pneumococcal-the-green-book-chapter-25 Last accessed: May 2022
  2. UPDATE REFERENCES
PP-UNP-GBR-4049. April 2023

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search 

for MHRA Yellow Card in Google Play or Apple App Store

 

Adverse events should also be reported to Pfizer Medical Information on 01304 616161

PfizerPro Account

To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.

Sign In or RegisterAccountSign Out

This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc

 

This website is brought to you by Pfizer Limited, a company registered in England 

and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ

 

Copyright © 2024 Pfizer Limited. All rights reserved.

 

VAT registration number GB201048427

PP-UNP-GBR-7866. January 2024
For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-UNP-GBR-7812. January 2024

YesNo
You are now leaving PfizerPro​​​​​

​​​​​​​You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site.​​​​​​​​​​​​​​

​​​​​​​PP-PFE-GBR-3858. November 2021​​​​​​​
​​​​​​​
You are now leaving PfizerPro
​​​​​​​
​​​​​​​You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned nor controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site other than the information or other materials relating to ​​​​​Pfizer medicines or 
business which it has provided or reviewed.

PP-PFE-GBR-3859. November 2021
​​​​​​​